WCM Investment Management LLC Sells 14,294 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

WCM Investment Management LLC cut its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 5.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 239,384 shares of the medical instruments supplier's stock after selling 14,294 shares during the period. WCM Investment Management LLC owned 0.97% of ICU Medical worth $33,552,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of ICU Medical by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock worth $416,176,000 after purchasing an additional 17,805 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of ICU Medical by 7.4% in the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock worth $109,920,000 after buying an additional 49,108 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of ICU Medical by 18.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier's stock valued at $83,788,000 after buying an additional 82,982 shares in the last quarter. Northern Trust Corp lifted its position in shares of ICU Medical by 11.1% during the 4th quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock valued at $62,431,000 after buying an additional 40,187 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of ICU Medical by 1.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier's stock valued at $47,196,000 after acquiring an additional 3,048 shares during the period. Hedge funds and other institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on ICUI shares. Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. Raymond James Financial lowered their target price on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research note on Friday, May 9th. KeyCorp dropped their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Finally, Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, ICU Medical presently has a consensus rating of "Buy" and a consensus target price of $192.67.

ICU Medical Price Performance

Shares of ICUI stock traded down $0.68 during mid-day trading on Friday, hitting $135.50. The company had a trading volume of 152,204 shares, compared to its average volume of 260,296. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.59 and a quick ratio of 1.52. The company has a market capitalization of $3.33 billion, a P/E ratio of -35.38 and a beta of 0.87. The stock's 50 day moving average price is $134.12 and its 200-day moving average price is $145.69. ICU Medical, Inc. has a 52-week low of $117.92 and a 52-week high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.49. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The firm had revenue of $599.49 million for the quarter, compared to analysts' expectations of $574.15 million. During the same period in the previous year, the firm posted $0.96 earnings per share. The business's revenue was up 6.7% compared to the same quarter last year. Equities research analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insider Transactions at ICU Medical

In other ICU Medical news, insider Ben Sousa sold 2,000 shares of the stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $137.36, for a total transaction of $274,720.00. Following the completion of the transaction, the insider owned 479 shares in the company, valued at $65,795.44. This trade represents a 80.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Elisha W. Finney sold 600 shares of the business's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $138.92, for a total transaction of $83,352.00. Following the completion of the sale, the director owned 3,252 shares in the company, valued at approximately $451,767.84. This trade represents a 15.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 36,097 shares of company stock valued at $4,860,156 over the last quarter. 1.50% of the stock is owned by insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.